HCWB (hcwbiologics.com) Sof foyda

HCWB (hcwbiologics.com) - kompaniyaning tovar belgisi

Onkologiya patentlari ishlanmalari barqarorligi HCW Biologics Inc. (HCWB) kompaniyasining daromadlarini qo'llab-quvvatlamoqda, uning GURU.Markets grafigidagi tarixiy dinamikasi joriy ko'rsatkich sifatida -0.02 ni ko'rsatmoqda. Fundamental ko'rsatkichlar gerontologiya va uzoq umr ko'rish sohalaridagi brend ishonchiga asoslangan, operatsion jarayonlar esa ichki R&D faoliyatini saqlab qolgan holda tashqi CRO hamkorlariga tayanadi.

HCWB (HCW Biologics Inc.) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

hcwbiologics.com (HCWB) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari HCW Biologics|HCWB - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi HCW Biologics|HCWB - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati HCW Biologics|HCWB - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi hcwbiologics.com|HCWB - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati HCW Biologics Inc.|HCWB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati HCW Biologics|HCWB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar HCW Biologics|HCWB - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi HCW Biologics|Shoshilinch likvidlik hcwbiologics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
HCWB - Sof foyda
Kompaniyaning jamlanma tahlili:HCW Biologics Inc.
HCW Biologics, Inc. asosiy tovari

Ushbu ko'rsatkich biznesning kunlik sof moliyaviy natijasini aks ettiradi va investorlarga boshqaruv tuzatishlarini istisno qilgan holda, ekstremal holatlarni aniqlash orqali operatsion siklning joriy bosqichini belgilash imkonini beradi. HCW Biologics Inc. (HCWB) kompaniyasining hisobotdagi daromadlarini tahlil qilish orqali, terapevtik platformalarning diversifikatsiyasi va HCW Biologics Inc. (HCWB) ning turli klinik dasturlari bo'ylab risklarning taqsimlanishi emitentning haqiqiy naqd pul samaradorligiga qanday ta'sir qilishini baholash mumkin.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Yakuniy foyda PHAR (Pharming Corp)|NKTR: Sof foyda|Sof daromad upstreambio.com|Sof daromad ZBIO|Sof daromad Immunome Inc (IMNM)|Sof daromad GOSS (Gossamer Corp)|KALV (KalVista Corp) - Yakuniy foyda|Sof foyda SEPN (Septerna Inc)|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|Sof moliyaviy natija Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Astria Corp (ATXS)|Kompaniyaning sof foydasi enGene Holdings Inc.|Kompaniyaning sof foydasi RAPT|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS - Kompaniyaning sof daromadi|Sof foyda KYTX (Kyverna)|Yillik sof foyda Tiziana Life Sciences, Ltd.|Cabaletta Bio, Inc. - Sof foyda|Sof moliyaviy natija ventyxbio.com VTYX|THTX: Sof foyda|Sof daromad Avalo Therapeutics, Inc.|Kompaniyaning sof foydasi Eledon|Agenus, Inc (AGEN) - Sof moliyaviy natija|Sof daromad CLYM (Climb Bio Inc)|ZURA (zurabio.com) - Yakuniy foyda|Sof foyda ATYR (aTyr Pharma)|Sof moliyaviy natija Adagene Inc (ADAG)|IMA - Kompaniyaning sof foydasi|STTK (Shattuck Labs, Inc.) - Kompaniya foydasi|EQ: Sof foyda|Sof daromad Connect Biopharma Holdings Limited|Sof daromad IMUX|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Sof foyda IFRX|XFOR (X4 Pharmaceuticals, Inc) - Yakuniy foyda|Sof foyda ACET (Adicet Bio, Inc.)|CELU - Sof daromad|INMB: Sof daromad|Barinthus Biotherapeutics PLC (BRNS) - Sof daromad|KZR: Sof foyda|SABS (SAB Biotherapeutics Inc) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Akari Therapeutics|Enlivex Therapeutics, Ltd. - Soliqdan keyingi foyda|Sof foyda QTTB|GOVX (GeoVax Labs) - Yakuniy foyda|Sof foyda EDSA (Edesa)|Sof foyda iBio Corporation IBIO|CARM - Kompaniyaning sof foydasi|Yakuniy foyda XTLB (xtlbio.com)|boltbio.com (BOLT) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Sof daromad GRI (GRI Bio, Inc.)|XRTX (xortx.com) - Yakuniy foyda|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Sof daromad ALLK|Sof foyda HOOKIPA|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Kompaniya foydasi|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Kompaniyaning sof daromadi|Third Harmonic Bio, Inc. - Sof foyda